Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications
- PMID: 36277013
- PMCID: PMC9586779
- DOI: 10.1155/2022/9988513
Association between ERCC1 Gene Polymorphism (rs11615) and Colorectal Cancer Susceptibility: A Meta-Analysis of Medical Image Fusion and Safety Applications
Abstract
Colorectal cancer (CRC) is a malignant tumor of the colorectal mucosa epithelial tissue transformed. The fusion of data for medical imaging has become a central issue in such biomedical applications as image-guided surgery and radiotherapy. Currently, CRC has been one of the most threatening tumors affecting people's health worldwide. The excision repair cross-complementation group 1 (ERCC1) is a key enzyme for nucleotide excision repair (NER). Emerging epidemiological studies have indicated that the presence of colorectal cancer (CRC) may be relevant to the ERCC1 rs11615 genetic polymorphism. However, the results of ERCC1 rs11615 on CRC in these studies are controversial. We searched PubMed, Web of Science, Embase, CNKI, and CBM databases for the effects of ERCC1 rs11615 variant on CRC development. There was no meta-analysis focused on the diagnosis of colorectal cancer with ERCC1 rs11615 variant. We creatively carried out a meta-analysis of nine case-control studies and used Stata (version 12.0) software to integrate the pooled odds ratios (ORs) corresponding to a 95% confidence interval (CI) of overall and subgroup analysis. Our results suggest that a significant correlation was observed between rs11615 and the susceptibility of CRC OR 95% CI = 1.13 (1.04-1.23) under an allele genetic model and OR 95% CI = 1.14 (1.01-1.30) under a dominant genetic model for overall CRC. Significant statistical difference was also noted in Asians rather than Caucasians based on the ethnicity subgroups. These results suggested that there is a certain association between rs11615 and the susceptibility of colorectal cancer in the Asian populations.
Copyright © 2022 Min Liu et al.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures




Similar articles
-
The Contribution of Excision Repair Cross-complementing Group 1 Genotypes to Colorectal Cancer Susceptibility in Taiwan.Anticancer Res. 2017 May;37(5):2307-2313. doi: 10.21873/anticanres.11568. Anticancer Res. 2017. PMID: 28476796
-
ERCC1 rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individuals.Biosci Rep. 2018 Jun 21;38(3):BSR20180440. doi: 10.1042/BSR20180440. Print 2018 Jun 29. Biosci Rep. 2018. PMID: 29752341 Free PMC article.
-
Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.Crit Rev Eukaryot Gene Expr. 2017;27(3):267-275. doi: 10.1615/CritRevEukaryotGeneExpr.2017019713. Crit Rev Eukaryot Gene Expr. 2017. PMID: 29199611 Review.
-
Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies.Clin Transl Oncol. 2015 Sep;17(9):710-9. doi: 10.1007/s12094-015-1298-7. Epub 2015 May 29. Clin Transl Oncol. 2015. PMID: 26022132
-
Polymorphisms of nucleotide excision repair genes associated with colorectal cancer risk: Meta-analysis and trial sequential analysis.Front Genet. 2022 Oct 31;13:1009938. doi: 10.3389/fgene.2022.1009938. eCollection 2022. Front Genet. 2022. PMID: 36386844 Free PMC article.
References
-
- Pellegrini M. L., Argibay P., Gómez D. E. Genetics and epigenetics of colorectal cancer. Acta Gastroenterologica Latinoamericana . 2011;41:247–261. - PubMed
-
- Shen M. R., Jones I. M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Research . 1998;58(4):604–608. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical